University of Cambridge’s DIOS-CoVax2 COVID-19 candidate set for autumn human trials

On Wednesday, in a statement, the University of Cambridge said, it aims to start clinical trials of its COVID-19 candidate in autumn. The development comes in the wake following funding to the tune of 1.9 million pounds from the British government. The approach adopted by the scientists behind the vaccine uses genetic sequences of all…

U.S. unveils procedures which shields telecom networks from national security threats

In a significant development, the United States has unveiled a procedure which is aimed at protecting its telecommunications networks as well as their supply chains, from national security threats. In May 2019, U.S. President Donald Trump had issued an executive order declaring a national emergency which bars U.S. companies from using telecommunications equipment made by…